January 18, 2012 – Clinical Trial Services Contract in Rett Syndrome with Neuren Pharmaceuticals Ltd

Posted by on Jan 18, 2012 in Press Release | 0 comments

Autism Therapeutics announced today that In the second half of 2011, Autism Therapeutics Ltd signed a contract with Neuren Pharmaceuticals Ltd. to provide clinical trial services. The Company is supporting Neuren in planned clinical studies of NNZ-2566 in Rett Syndrome, making use of Autism Therapeutics’ experience and expertise in clinical study design and subpopulation/stratification design in developmental disorders.

AT Press Release January 18 2012 (Neuren Contract Announcement)